Advertisement

Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 1581 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Igem Therapeutics–Iontas: antibody cancer drug, 201804– collab identification IgE antibodies against two cancer targets 2018-04-04
Iontas–Zyme Communications: public relations, 201804 service existent by Zyme 2018-04-04
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
AstraZeneca–Compugen: antibody cancer drug, 201804– license $10m upfront + $200m milestones + royalties developm bi-/multi-specific ABs to MedImmune 2018-04-02
Novartis–GSK: investment, 201803– acquisition $13b of 36.5% stake of Novartis in OTC joint venture giving GSK 100% ownership 2018-03-27
Deinove–Redx Pharma: antibiotics, 201803– option + license agreem for Redx’ Novel Bacterial Topoisomerase Inhibitor programme 2018-03-22
Oxford Nanopore–China Construction Bank: investment, 201803 private placement totalling £100m ($140m) incl new investor CCBI 2018-03-20
Oxford Nanopore–Hostplus: investment, 201803 private placement totalling £100m ($140m) incl new investor Hostplus 2018-03-20
Oxford Nanopore–SEVERAL: investment, 201803 private placement £100m ($140m) incl GIC + CCBI + Hostplus + existing investors 2018-03-20
Oxford Nanopore–Singapore (govt): investment, 201803 private placement totalling £100m ($140m) incl new investor GIC 2018-03-20
Biocatalysts Ltd–BRAIN: investment, 201803 acquisition of majority stake in Biocatalysts Ltd by BRAIN AG 2018-03-17
Kiadis–Optimum Strategic Communications: public relations, 201803 service existent by Optimum 2018-03-14
OxSyBio–SEVERAL: investment, 201803 financing round Series A £10m led by Woodford + incl IP Group + Parkwalk Advisors 2018-03-12
Oxford Vacmedix–SEVERAL: investment, 201803 financing round Series A $12.5m from Cancer ROP (KR) + existing Chinese investors 2018-03-06
Autolus–SEVERAL: investment, 201803– filing of draft registration statement with SEC for potential US IPO 2018-03-05
Owlstone–Aviva: investment, 201803 financing round totalling £11m incl existent + co-lead investor Aviva Ventures 2018-03-05
Owlstone–Horizons Ventures: investment, 201803 financing round totalling £11m incl new + co-lead investor Horizons Ventures 2018-03-05
Owlstone–Huntsworth: public relations, 201803 service existent IR by Citigate Dewe Rogerson 2018-03-05
Owlstone–SEVERAL: investment, 201803 financing round £11m ($15m) co-led by Horizons Ventures + Aviva Ventures 2018-03-05
BioPharmaSpec–Danaher: mass spectrometer, 201803 supply existent Sciex 5800 MALDI TOF/TOF mass spetrometers 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo G2 Q-TOF MS systems with ES + Nanospray 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo G2-XS Q-TOF MS systems with ES + Nanospray 2018-03-03
BioPharmaSpec–Waters: mass spectrometer, 201803 supply existent Xevo TQ-S systems with ESAB 2018-03-03
Acacia Pharma–Huntsworth: public relations, 201803 service existent by Citigate Dewe Rogerson 2018-03-02
Agilent–Imperial College: analytical technology, 201802– collab with new Agilent sponsored Measurement Site at ICL incl demo + showcasing solutions 2018-02-28
Arix Bioscience–SEVERAL: investment, 201802–201803 capital increase £87m with 38.6m new ordinary shares to new + existing investors 2018-02-28
Imperial College–Agilent: analytical instruments, 201802– supply of instruments for new Agilent sponsored Measurement Site at ICL 2018-02-28
Viela Bio–SEVERAL: investment, 201802 up to $250m funding from investor consortium at spin-out with AZ remaining largest minority shareholder 2018-02-28
LifeArc–Zyme Communications: public relations, 201802 service existent by Zyme 2018-02-27
City Analysts–Eurofins: investment, 201802 acquisition of City Analysts Ltd by Eurofins 2018-02-23
Congenica–Science Foundation Ireland: bioinformatics, 201802– collab developm diagnosis of genetic epilepsy using Sapientia s/w with FutureNeuro 2018-02-12
Lonza–Kirkstall: cell culture system, 201802– collab ww marketing + distribution of Quasi Vivo System by Lonza 2018-02-12
Nosopharm–Andrew Lloyd Associates: public relations, 201802 service existent by ALA 2018-02-12
Impact Biomedicines–Medicxi Ventures: investment, 201801 existing investor 2018-02-07
LCF Rothschild–SEVERAL: investment, 201802 closing €345m of BioDiscovery 5 fund of EdRIP 2018-02-07
Acacia Pharma–SEVERAL: investment, 201802–201803 initial global offering €40m private placement 11.1m shares at €3.6 + listing on Euronext Brussels 2018-02-05
CustoMem–EU (govt): grant, 201802– Horizon 2020 grant €1.4m to support pilot phase of new bio-adsorbent CustoMem Granular Media 2018-02-05
Faron Pharmaceuticals–Lyomark Pharma: Traumakine, 201802– supply contract manfucturing by Lyocontract GmbH 2018-02-05
Faron Pharmaceuticals–Rentschler: Traumakine, 201802 supply existent contract manfucturing by Rentschler Biopharma SE 2018-02-05
Faron Pharmaceuticals–Westwicke Partners: public relations, 201802 service existent US IR by Westwicke Partners 2018-02-05
LIG Biowise–Phoenix Bridge (HK): investment, 201802 financing round Series A totalling £1.8m incl lead investor Phoenix Bridge 2018-02-05
LIG Biowise–SEVERAL: investment, 201802 financing round Series A £1.8m led by Phoenix Bridge (HK) 2018-02-05
Syndesi Therapeutics–SEVERAL: investment, 201802 financing round Series A €17m co-led by Novo Seeds + Fountain Healthcare 2018-02-01
Evonetix–SEVERAL: investment, 201801 financing round Serise A £9m ($12.3m) co-led by DVCV + Draper Esprit 2018-01-30
Evonetix–Zyme Communications: public relations, 201801 service existent by Zyme 2018-01-30
Foundry Innovation & Research 1–SEVERAL: investment, 201801 financing round Series C €40m of FIRE1 led by new investor Gilde Healthcare 2018-01-30
Concept Life Sciences–Spectris: investment, 201801 acquisition £163m on debt/cash-free basis from Equistone Partners + company management 2018-01-26
Selcia–Eurofins: investment, 201801 acquisition of Selcia Ltd by Eurofins 2018-01-25
ImmuPharma–SEVERAL: investment, 201801 placing £10m of 6.945m new ordinary shares at 144p/share 2018-01-24
Almac–Salesforce.com: CRM software, 201801– supply Almac Clinical Technology implements Salesforce Service Cloud 2018-01-23
Concept Life Sciences–Alderley Analytical: analytical services, 201801– collab partnership to provide bioanalytical + DMPK services 2018-01-18
Adverum Biotechnologies–Synpromics: genomic technology, 201801 collab existent 2018-01-17
BIA Separations–Zyme Communications: public relations, 201801 service existent by Zyme 2018-01-17
BioMarin–Synpromics: genomic technology, 201801 collab existent 2018-01-17
Cellnovo–Flextronics: contract manufacturing, 201801 supply existent production of Cellnovo Diabetes Monitoring System + Cartridges by Flex 2018-01-17
General Electric–Synpromics: genomic technology, 201801 collab existent with GE Healthcare 2018-01-17
Homology Medicines–Synpromics: genomic technology, 201801 collab existent 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
Synpromics–Sciad Communications: public relations, 201801 service existent by Sciad 2018-01-17
Uniqure–Synpromics: genomic technology, 201801 collab existent 2018-01-17
Metrion Biosciences–SEVERAL: investment, 201801– crowd funding targeting £600k via SyndicateRoom 2018-01-16
Waters–Spectris: analytical instruments, 201801– collab co-marketing agreem with Malvern Panalytical for Omnisec Reveal with Acquity APC system 2018-01-16
e-Therapeutics–Biorelate: drug discovery software, 201801– collab €na using AI to improve computational drug discovery technology 2018-01-15
e-Therapeutics–Intellegens: drug discovery software, 201801– collab €na using AI to improve computational drug discovery technology 2018-01-15
Vaccitech–SEVERAL: investment, 201801 financing round Series A £20m with GV + Sequoia China + OSI + Neptune Ventures 2018-01-15
CombiGene–United Kingdom (govt): gene therapy manufacturing, 201801– collab developm manufacturing processes for CG01 with CGT Catapult 2018-01-12
Intelligent Pharma–Mind the Byte: investment, 201801 acquisition €na 100% of Intelligent Pharma by Mind the Byte 2018-01-11
KWS Biotest–Charles River: investment, 201801 acquisition of KWS Biotest Ltd for £15m cash + £3m milestones 2018-01-11
Mind the Byte–SEVERAL: investment, 201801– financing round €3m (1/3 of company) to finance acquisition of Intelligent Pharma PLANNED 2018-01-11
Sosei–Imperial College: drug discovery, 201801– collab r+d focused on GPCR disease targets in gastro-interstinal tract Heptares 2018-01-10
Structural Genomics Consortium–Enamine: chemical compound libraries, 201801– supply new generation of Diamond-SGC-iNEXT (DSI) Poised Library 2018-01-10
BioNTech–Scancell: cancer immunotherapy, 201801– collab research using Moditope platform w excl license option for BioNTech 2018-01-09
F-Star–Instinctif Partners: public relations, 201801 service existent by Instinctif for EU + RoW 2018-01-09
F-Star–Lazar Partners: public relations, 201801 service existent by Lazar Partners for US 2018-01-09
Luxcel Biosciences–Agilent: investment, 201801 acquisition €na of Luxcel by Agilent 2018-01-09
Orchard Therapeutics–JPMorgan Chase: investor conference, 201801 supply service Orchard presents at JP Morgan Healthcare Conference 2018 2018-01-09
General Electric–Roche: diagnostics, 201801– collab developm integrated digital + IVD + in vivo diagnostics platform for oncology + critical care 2018-01-08
Hookipa Biotech–JPMorgan Chase: investor conference, 201801 supply service Hookipa presents at JP Morgan Healthcare Conference 2018 2018-01-08
Mallinckrodt–JPMorgan Chase: investor conference, 201801 supply service Mallinckrodt presents at JP Morgan Healthcare Conference 2018 2018-01-08
Storm Therapeutics–Optimum Strategic Communications: public relations, 201801 service existent by Optimum 2018-01-08
Storm Therapeutics–Otsuka: investment, 201801 investment £4m by Taiho Ventures LLC extends Series A round to £16m 2018-01-08
United Kingdom (govt)–Edico Genome: bioinformatics, 201801– supply + collab Genomics England to adopt DRAGEN platform for sequending data analysis 2018-01-08
Adaptimmune–Hitachi: cell therapy manufacturing, 201801 existent manufacturing of SPEAR-T cells by PCT 2018-01-05
Adaptimmune–United Kingdom (govt): cell therapy manufacturing, 201801– dedicated vector mftg space at CGT Catapult Manufacturing Centre 2018-01-05
Takeda–Denali Therapeutics: neurological drugs, 201801– collab + option agreem for 3 drug candidates for neurodegenerative diseases 2018-01-05
Indivior–Addex: ADX71441, 201801– license + collab agreem $5m upfront + $4m research funding + $330m milestones plus royalties 2018-01-03
Sucampo–Mallinckrodt: investment, 201712– acquisition $1.2b cash tender offer at $18/share ANNOUNCED 2017-12-26
Orchard Therapeutics–LifeSci: public relations, 201712 service existent by LifeSci Public Relations 2017-12-22
Orchard Therapeutics–SEVERAL: investment, 201712 financing round Series B £85m co-led by Baillie Gifford + ORI Capital 2017-12-20
Autifony–Instinctif Partners: public relations, 201712 service existent by Instinctif 2017-12-18
Boehringer–Autifony: CNS drugs, 201712– collab €25m upfront + up to total of €627.5m excl option to acquire KV3.1/3.2 positive modulators for BI 2017-12-18
Roche–Horizon Discovery: reference standards, 201712– collab developm + supply of FFPE reference standards for ICH-NTRK assays for Roche Dx 2017-12-18
Ablynx–Leucadia: investor conference, 201711 supply service Ablynx presents at Annual Jefferies Healthcare Conference London 2017-12-16
BPCE–Instinctif Partners: public relations, 201712 service existent for Seventure Partners by Instinctif Partners 2017-12-14
Life Sciences Partners–Optimum Strategic Communications: public relations, 201712 service existent by Optimum 2017-12-12
NorthSea Therapeutics–Instinctif Partners: public relations, 201712 service existent by Instinctif Partners 2017-12-12
ProImmune–Zyme Communications: public relations, 201712 service existent by Zyme 2017-12-12
PGS.Holland–bio.logis: genetic software, 201712– distribution of bio.logis GIMS in Benelux + Scandinavia + UK by PGS.Holland BV 2017-12-08
Bluebird Bio–TC BioPharm: T cell therapy, 201712– collab r+d $16m upfront + milestones + royalties CAR-engineered gamma delta T cells for cancer 2017-12-07
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group ChinaBio Partnering Forum 2018 Suzhou CBPF April 120x180px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px